oxybutynin has been researched along with Amentia in 13 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study aimed to develop nanolipid carrier (NLC) loaded transdermal system of rivastigmine for bioavailability enhancement." | 5.51 | Optimization and characterization of rivastigmine nanolipid carrier loaded transdermal patches for the treatment of dementia. ( Chauhan, MK; Sharma, PK, 2019) |
| " Patients received stepwise pain treatment in which those who did not use analgesics were randomized to receive either paracetamol (3 g/day) or placebo tablets; those who already used pain treatment were allocated to buprenorphine transdermal system (max." | 5.27 | Effects of pain treatment on sleep in nursing home patients with dementia and depression: A multicenter placebo-controlled randomized clinical trial. ( Bjorvatn, B; Blytt, KM; Flo, E; Husebo, B, 2018) |
| " According to a predefined scheme for 8 weeks, all patients in the intervention group received individual daily pain treatment with acetaminophen, extended release morphine, buprenorphine transdermal patch, and/or pregabaline." | 5.19 | The response of agitated behavior to pain management in persons with dementia. ( Aarsland, D; Ballard, C; Cohen-Mansfield, J; Husebo, BS; Seifert, R, 2014) |
| "Pain medication significantly improved pain in the intervention group, with indications that acetaminophen also improved ADL function." | 5.19 | Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial. ( Aarsland, D; Ballard, C; Corbett, A; Husebo, BS; Sandvik, RK; Seifert, R; Selbaek, G, 2014) |
| "Older adults receiving solifenacin and darifenacin in the 6 mo prior to diagnosis, and those receiving solifenacin, darifenacin, tolterodine, or fesoterodine in the year prior to diagnosis, have increased odds of incident dementia, compared with those receiving mirabegron." | 4.12 | Receipt of Overactive Bladder Drugs and Incident Dementia: A Population-based Case-control Study. ( Gomes, T; Herschorn, S; Jarvi, K; Juurlink, D; Matta, R; Nam, RK, 2022) |
| " Herein we report a patient with opioid-induced delirium associated with the administration of buprenorphine patches that was well below the indicated therapeutic range limit." | 3.79 | A case of topical opioid-induced delirium mistaken as behavioural and psychological symptoms of dementia in demented state. ( Ito, G; Kanemoto, K, 2013) |
| "Rivastigmine is an acetylcholine esterase inhibitor used in the treatment of dementia." | 3.78 | A fatal outcome after unintentional overdosing of rivastigmine patches. ( Hägg, S; Jönsson, AK; Lövborg, H, 2012) |
| "Elderly with dementia are prescribed opioids more frequent than elderly without." | 1.56 | The Use of Opioids and Antipsychotics in Elderly with Dementia - Have Opioids Replaced Antipsychotics in Treating Behavioral Symptoms in Dementia? ( Christensen, AN; Gasse, C; Jensen-Dahm, C; Waldemar, G, 2020) |
| "The present study aimed to develop nanolipid carrier (NLC) loaded transdermal system of rivastigmine for bioavailability enhancement." | 1.51 | Optimization and characterization of rivastigmine nanolipid carrier loaded transdermal patches for the treatment of dementia. ( Chauhan, MK; Sharma, PK, 2019) |
| "Type of menopause was not significantly associated with cognitive function." | 1.40 | Impact of a premature menopause on cognitive function in later life. ( Amieva, H; Ancelin, ML; Berr, C; Carrière, I; Ritchie, K; Rouaud, O; Ryan, J; Scali, J, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Matta, R | 1 |
| Gomes, T | 1 |
| Juurlink, D | 1 |
| Jarvi, K | 1 |
| Herschorn, S | 1 |
| Nam, RK | 1 |
| Welk, B | 1 |
| Richardson, K | 1 |
| Panicker, JN | 1 |
| Newman, DK | 1 |
| Sugiyama, T | 1 |
| Matsuda, H | 1 |
| Oonishi, N | 1 |
| Kiwamoto, H | 1 |
| Esa, A | 1 |
| Park, YC | 1 |
| Kurita, T | 1 |
| Uchida, A | 1 |
| Kunikata, S | 1 |
| Jensen-Dahm, C | 1 |
| Christensen, AN | 1 |
| Gasse, C | 1 |
| Waldemar, G | 1 |
| Srivastava, PK | 1 |
| Thakkar, HP | 1 |
| Blytt, KM | 1 |
| Bjorvatn, B | 1 |
| Husebo, B | 1 |
| Flo, E | 1 |
| Chauhan, MK | 1 |
| Sharma, PK | 1 |
| Husebo, BS | 2 |
| Ballard, C | 2 |
| Cohen-Mansfield, J | 1 |
| Seifert, R | 2 |
| Aarsland, D | 2 |
| Ito, G | 1 |
| Kanemoto, K | 1 |
| Ryan, J | 1 |
| Scali, J | 1 |
| Carrière, I | 1 |
| Amieva, H | 1 |
| Rouaud, O | 1 |
| Berr, C | 1 |
| Ritchie, K | 1 |
| Ancelin, ML | 1 |
| Sandvik, RK | 1 |
| Selbaek, G | 1 |
| Corbett, A | 1 |
| Lövborg, H | 1 |
| Jönsson, AK | 1 |
| Hägg, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Impact of Pain on Behavioural Disturbances in Patients With Moderate and Severe Dementia. A Cluster Randomized Trial[NCT01021696] | Phase 2/Phase 3 | 352 participants (Actual) | Interventional | 2009-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for oxybutynin and Amentia
| Article | Year |
|---|---|
The cognitive effect of anticholinergics for patients with overactive bladder.
Topics: Benzhydryl Compounds; Benzofurans; Cholinergic Antagonists; Cognition; Cognitive Dysfunction; Dement | 2021 |
3 trials available for oxybutynin and Amentia
| Article | Year |
|---|---|
Effects of pain treatment on sleep in nursing home patients with dementia and depression: A multicenter placebo-controlled randomized clinical trial.
Topics: Acetaminophen; Adult; Aged; Analgesics; Buprenorphine; Dementia; Depressive Disorder; Double-Blind M | 2018 |
The response of agitated behavior to pain management in persons with dementia.
Topics: Acetaminophen; Aged, 80 and over; Analgesics; Buprenorphine; Delayed-Action Preparations; Dementia; | 2014 |
Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial.
Topics: Acetaminophen; Activities of Daily Living; Aged; Aged, 80 and over; Analgesics; Buprenorphine; Clini | 2014 |
9 other studies available for oxybutynin and Amentia
| Article | Year |
|---|---|
Receipt of Overactive Bladder Drugs and Incident Dementia: A Population-based Case-control Study.
Topics: Aged; Canada; Case-Control Studies; Dementia; Humans; Muscarinic Antagonists; Solifenacin Succinate; | 2022 |
The MATRIX study: evaluating the data in older adults.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Attitude to Health; Dementia; Diapers, Ad | 2008 |
[Anticholinergic therapy of urinary incontinence and urinary frequency associated with the elderly--with special reference to dementia].
Topics: Aged; Aged, 80 and over; Butylamines; Dementia; Drug Administration Schedule; Drug Therapy, Combinat | 1993 |
The Use of Opioids and Antipsychotics in Elderly with Dementia - Have Opioids Replaced Antipsychotics in Treating Behavioral Symptoms in Dementia?
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antipsychotic Agents; Behavioral Symptoms; Cross-Sectio | 2020 |
Vinpocetine loaded ultradeformable liposomes as fast dissolving microneedle patch: Tackling treatment challenges of dementia.
Topics: Animals; Cell Line, Transformed; Dementia; Female; Humans; Liposomes; Maze Learning; Microinjections | 2020 |
Optimization and characterization of rivastigmine nanolipid carrier loaded transdermal patches for the treatment of dementia.
Topics: Administration, Cutaneous; Animals; Blood Specimen Collection; Chromatography, High Pressure Liquid; | 2019 |
A case of topical opioid-induced delirium mistaken as behavioural and psychological symptoms of dementia in demented state.
Topics: Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Confusion; Delirium; Dementia; Female; Halluci | 2013 |
Impact of a premature menopause on cognitive function in later life.
Topics: Aged; Aged, 80 and over; Cognition; Dementia; Estradiol; Estrogen Replacement Therapy; Estrogens; Fe | 2014 |
A fatal outcome after unintentional overdosing of rivastigmine patches.
Topics: Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Drug Labeling; Drug Overdose; Fatal Outcome; | 2012 |